98%
921
2 minutes
20
This commentary responds to the important study by Ludwig et al. on using smartphone data and critical slowing down (CSD) to predict bipolar disorder (BD) relapse. While commending the study's methodological rigor, we highlight a key paradoxical finding: a decrease in activity variance preceding manic episodes, which challenges the classic CSD model. We posit this may not be a failure of the theory but instead reveals a distinct pre-manic signature of behavioral 'rigidification' rather than instability. Furthermore, we discuss the ambiguity of the 'euthymic' baseline in a clinically complex, medicated population, suggesting that unmeasured pharmacological effects may confound the detected signals. The commentary argues that the limited individual-level predictive power underscores the need to shift from searching for universal nomothetic signals to developing personalized, idiographic (N-of-1) models. Ultimately, we conclude that Ludwig et al.'s work is pivotal in reframing the research agenda towards more nuanced, individualized, and clinically translatable digital phenotyping for BD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jad.2025.120116 | DOI Listing |
Neuropsychiatr Dis Treat
September 2025
Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.
Parkinson's disease (PD) represents a progressive neurodegenerative disorder with escalating global burden, with mechanistic studies revealing α-synuclein propagation through gut-brain axis, mitochondrial defects, and neuroinflammatory cascades driven by genetic-environmental interplay. Recent advancements in diagnostic paradigms have successfully combined α-synuclein seed amplification assays with multimodal neuroimaging techniques, achieving an impressive diagnostic accuracy of 92% during the prodromal stages of disease. Phase II trials highlight disease-modifying potential of α-synuclein-targeting immunotherapies (40% reduction in motor decline) and LRRK2 kinase inhibitors showing blood-brain barrier penetration.
View Article and Find Full Text PDFInt Psychogeriatr
September 2025
Department of Psychology and Neuroscience, Temple University, Philadelphia, PA, United States. Electronic address:
Background: As demand for mental healthcare access grows among older adult populations, digital mental health tools have emerged as promising tools. However, bridging the digital divide among older technology users remains critical. This post-hoc analysis evaluated potential factors influencing the adoption of a digital mental health tool in older adults.
View Article and Find Full Text PDFDiabetologia
September 2025
Centre Universitaire de Diabétologie et de ses Complications, AP-HP, Hôpital Lariboisière, Paris, France.
Aims/hypothesis: Severe hypoglycaemia events (SHE) remain frequent in people with type 1 diabetes despite advanced diabetes technologies. We examined whether time below range (TBR) 3.9 mmol/l (70 mg/dl; TBR70) or 3.
View Article and Find Full Text PDFTheor Appl Genet
September 2025
Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany.
The German Federal Ex Situ Genebank for Agricultural and Horticultural Crops (IPK) harbours over 3000 pea plant genetic resources (PGRs), backed up by corresponding information across 16 key agronomic and economical traits. The unbalanced structure and inconsistent format of this historical data has precluded effective leverage of genebank accessions, despite the opportunities contained in its genetic diversity. Therefore, a three-step statistical approach founded in linear mixed models was implemented to enable a rigorous and targeted data curation.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
Boston University Alzheimer's Disease Research Center and BU CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
We describe the rationale, methodology, and design of the Boston University Alzheimer's Disease Research Center (BU ADRC) Clinical Core (CC). The CC characterizes a longitudinal cohort of participants with/without brain trauma to characterize the clinical presentation, biomarker profiles, and risk factors of post-traumatic Alzheimer's disease (AD) and AD-related dementias (ADRD), including chronic traumatic encephalopathy (CTE). Participants complete assessments of traumatic brain injury (TBI) and repetitive head impacts (RHIs); annual Uniform Data Set (UDS) and supplementary evaluations; digital phenotyping; annual blood draw; magnetic resonance imaging (MRI) and lumbar puncture every 3 years; electroencephalogram (EEG); and amyloid and/or tau positron emission tomography (PET) on a subset.
View Article and Find Full Text PDF